Literature DB >> 27122910

High Sensitivity C Reactive Protein (hs-CRP) in Adolescent and Young Adult Patients with History of Kawasaki Disease.

Yung-Chuan Chen1, Ching-Tsuen Shen1, Nan-Koong Wang1, Yi-Ling Huang2, Hsin-Hui Chiu3, Chun-An Chen3, Shuenn-Nan Chiu3, Ming-Tai Lin3, Jou-Kou Wang3, Mei-Hwan Wu3.   

Abstract

BACKGROUND: For children with a history of Kawasaki disease (KD), low grade inflammation was generally reported to be associated with persistent coronary artery lesions (CAL). However, this association has not been clearly demonstrated to hold true in KD adolescents and young adults (10-25 years of age).
METHODS: We enrolled 104 subjects into our study, who were separated into the following 3 groups and controls: 1): 22 KD patients with angiography-confirmed CAL which persisted for an average of 12.5 years after onset of KD; 2) 38 KD patients with regressed aneurysms; 3) 44 KD patients without any coronary complications from the disease onset; and 4) 31 age-matched (18.7 ± 1.88 years old) healthy controls. Plasma levels of high-sensitivity C reactive protein (hs-CRP) were measured for all participants.
RESULTS: Plasma levels of hs-CRP were significantly higher in KD patients than in the controls, regardless of their coronary severity. However, there was no significant difference in hs-CRP levels among KD patients with different severities of CAL. Of the candidate risk factors of elevated hs-CRP such as body mass index, gender, coronary severity, and levels of high-density lipoprotein-cholesterol, linear regression analysis showed the only independent predictor of hs-CRP levels was BMI (β = 0.306, p = 0.01), rather than patient grouping (p = 0.091).
CONCLUSIONS: Our study found that levels of hs-CRP are significantly higher in adolescent and young adult patients with a history of KD, compared with age-matched controls. Low grade inflammation may play a minor role when KD patients enter into adulthood. body mass index (BMI), rather than coronary severity, was independently associated with the elevation of hs-CRP levels, one of biomarkers for further cardiovascular event. Therefore, ongoing control and management of BMI may be one of beneficial strategies that can be employed to help avoid elevation of hs-CRP levels in KD patients. KEY WORDS: Adolescents; High sensitivity-C reactive protein; Kawasaki disease; Young adult.

Entities:  

Year:  2015        PMID: 27122910      PMCID: PMC4804970          DOI: 10.6515/acs20150424e

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  23 in total

1.  Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function.

Authors:  M Iemura; M Ishii; T Sugimura; T Akagi; H Kato
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

2.  Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia.

Authors:  Lori B Daniels; Matthew S Tjajadi; Hannah H Walford; Susan Jimenez-Fernandez; Vera Trofimenko; Daryl B Fick; Hoang-Anh L Phan; Peter E Linz; Keshav Nayak; Andrew M Kahn; Jane C Burns; John B Gordon
Journal:  Circulation       Date:  2012-05-17       Impact factor: 29.690

3.  Significant relationship between serum high-sensitivity C-reactive protein, high-density lipoprotein cholesterol levels and children with Kawasaki disease and coronary artery lesions.

Authors:  Chun-Yen Ou; Yu-Fang Tseng; Cheng-Liang Lee; Yee-Hsuan Chiou; Kai-Sheng Hsieh
Journal:  J Formos Med Assoc       Date:  2009-09       Impact factor: 3.282

Review 4.  Diagnosis and therapy of Kawasaki disease in children.

Authors:  A S Dajani; K A Taubert; M A Gerber; S T Shulman; P Ferrieri; M Freed; M Takahashi; F Z Bierman; A W Karchmer; W Wilson
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

5.  Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease.

Authors:  A M Liu; M Ghazizadeh; Z Onouchi; G Asano
Journal:  Microvasc Res       Date:  1999-07       Impact factor: 3.514

6.  Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men.

Authors:  L E Rohde; C H Hennekens; P M Ridker
Journal:  Am J Cardiol       Date:  1999-11-01       Impact factor: 2.778

7.  Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease.

Authors:  Y F Cheung; M H K Ho; S C F Tam; T C Yung
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

8.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

9.  Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  A S Dajani; K A Taubert; M Takahashi; F Z Bierman; M D Freed; P Ferrieri; M Gerber; S T Shulman; A W Karchmer; W Wilson
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

10.  The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.

Authors:  K Durongpisitkul; V J Gururaj; J M Park; C F Martin
Journal:  Pediatrics       Date:  1995-12       Impact factor: 7.124

View more
  4 in total

1.  Platelet Endothelial Cell Adhesion Molecule-1 Gene Polymorphisms are Associated with Coronary Artery Lesions in the Chronic Stage of Kawasaki Disease.

Authors:  Wen-Hsien Lu; Sin-Jhih Huang; Yeong-Seng Yuh; Kai-Sheng Hsieh; Chia-Wan Tang; Huei-Han Liou; Luo-Ping Ger
Journal:  Acta Cardiol Sin       Date:  2017-05       Impact factor: 2.672

2.  Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease.

Authors:  Ming-Yu Liu; Hsin-Min Liu; Chia-Hui Wu; Chin-Hao Chang; Guan-Jr Huang; Chun-An Chen; Shuenn-Nan Chiu; Chun-Wei Lu; Ming-Tai Lin; Luan-Yin Chang; Jou-Kou Wang; Mei-Hwan Wu
Journal:  BMC Pediatr       Date:  2017-06-06       Impact factor: 2.125

3.  Prognosis and Risk Factors of Coronary Artery Lesions before Immunoglobulin Therapy in Children with Kawasaki Disease

Authors:  Huixian Qiu; Chang Jia; Zhenquan Wang; Yuee He; Xing Rong; Rongzhou Wu; Maoping Chu; Hongying Shi
Journal:  Balkan Med J       Date:  2020-07-28       Impact factor: 2.021

4.  Long-Term Hypermethylation of FcγR2B in Leukocytes of Patients with Kawasaki Disease.

Authors:  Ling-Sai Chang; Hong-Ren Yu; Chiao-Lun Chu; Kuang-Den Chen; Ying-Hsien Huang; Mindy Ming-Huey Guo; Ken-Pen Weng; Ho-Chang Kuo
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.